Yuan Wang

Yuan Wang

Auto-generated profile, based on publicly available information

Yuan Wang

Department of Computer Science, Princeton University, Princeton, New Jersey

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2024 in Science
Verified
Journal Article
Closed access
MSMilos S. Simic
Milos S. Simic
PWPayal B. Watchmaker
Payal B. Watchmaker
SGSasha Gupta
Sasha Gupta
YWYuan Wang
Yuan Wang
SSSharon A. Sagan
Sharon A. Sagan
WLWendell A. Lim
Wendell A. Lim
To engineer cells that can specifically target the central nervous system (CNS), we identified extracellular CNS-specific antigens, including components of the CNS extracellular matrix and surface molecules expressed on neurons or glial cells. Synthetic Notch receptors engineered to detect these antigens were used to program T cells to induce the expression of diverse payloads only in the brain. CNS-targeted T cells that induced chimeric antigen receptor expression efficiently cleared primary and secondary brain tumors without harming cross-reactive cells outside of the brain. Conversely, CNS-targeted cells that locally delivered the immunosuppressive cytokine interleukin-10 ameliorated symptoms in a mouse model of neuroinflammation. Tissue-sensing cells represent a strategy for addressing diverse disorders in an anatomically targeted manner.

25 July 2023 in Nature Computational Science
Verified
Journal Article
Open access
PDF file
XCXi Chen
Xi Chen
YWYuan Wang
Yuan Wang
ACAntonio Cappuccio
Antonio Cappuccio
WCWan-Sze Cheng
Wan-Sze Cheng
FZFrederique Ruf Zamojski
Frederique Ruf Zamojski
SSStuart C. Sealfon
Stuart C. Sealfon
Resolving chromatin-remodeling-linked gene expression changes at cell-type resolution is important for understanding disease states. Here we describe MAGICAL (Multiome Accessibility Gene Integration Calling and Looping), a hierarchical Bayesian approach that leverages paired single-cell RNA sequencing and single-cell transposase-accessible chromatin sequencing from different conditions to map disease-associated transcription factors, chromatin sites, and genes as regulatory circuits. By simultaneously modeling signal variation across cells and conditions in both omics data types, MAGICAL achieved high accuracy on circuit inference. We applied MAGICAL to study Staphylococcus aureus sepsis from peripheral blood mononuclear single-cell data that we generated from subjects with bloodstream infection and uninfected controls. MAGICAL identified sepsis-associated regulatory circuits predominantly in CD14 monocytes, known to be activated by bacterial sepsis. We addressed the challenging problem of distinguishing host regulatory circuit responses to methicillin-resistant and methicillin-susceptible S. aureus infections. Although differential expression analysis failed to show predictive value, MAGICAL identified epigenetic circuit biomarkers that distinguished methicillin-resistant from methicillin-susceptible S. aureus infections.

3 October 2024 in Cell Systems
Verified
Journal Article
Closed access
YWYuan Wang
Yuan Wang
WTWilliam Thistlethwaite
William Thistlethwaite
ATAlicja Tadych
Alicja Tadych
FRFrederique Ruf-Zamojski
Frederique Ruf-Zamojski
DBDaniel J. Bernard
Daniel J. Bernard
OTOlga G. Troyanskaya
Olga G. Troyanskaya

8 October 2025 in Cancer Discovery
Verified
Journal Article
Open access
NGNofar Gumpert
Nofar Gumpert
Shira SagieShira Sagie
Shira Sagie
CAClaudia Arnedo-Pac
Claudia Arnedo-Pac
TBTomer Babu
Tomer Babu
CWChen Weller
Chen Weller
YSYardena Samuels
Yardena Samuels
New approaches that generate long-lasting therapeutic responses in patients with therapy-resistant metastatic cancer are urgently needed. To address this challenge, we developed Spot Neoantigens in Metastases (SpotNeoMet), a novel data-driven pipeline that systematically identifies recurrently presented neopeptides in treatment-resistant patients. We identified seven therapy resistance mutations predicted to produce neopeptides presented by common HLAs. Using HLA immunopeptidomics, we discovered three novel neopeptides derived from androgen receptor (AR) H875Y, a common metastatic castration-resistant prostate cancer (mCRPC) mutation. We validated these neoantigens as highly immunogenic and then isolated and characterized cognate T-cell receptors (TCR) from healthy donor peripheral blood mononuclear cells. We demonstrated that AR H875Y–specific TCRs are highly specific and kill prostate cancer cells presenting AR neopeptides in vitro and in vivo. Our new pipeline identifies novel immunotherapy targets and potential treatment options for patients with mCRPC. Moreover, SpotNeoMet offers a systematic route to identify “HLA–peptide” pairs and their cognate TCRs across treatment-resistant cancers. Significance: As the emergence of resistance to targeted treatments in patients with metastatic cancer, there is an urgent need for innovative therapeutic approaches for this population. Our study provides a new analytic framework to identify neoantigens from treatment-resistant mutations and a proof-of-concept T cell–based immunotherapy treatment for mCRPC.

4 November 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
YWYuan Wang
Yuan Wang
WTWilliam Thistlethwaite
William Thistlethwaite
ATAlicja Tadych
Alicja Tadych
FRFrederique Ruf-Zamojski
Frederique Ruf-Zamojski
DBDaniel J Bernard
Daniel J Bernard
OTOlga G. Troyanskaya
Olga G. Troyanskaya
Summary: To facilitate single-cell multi-omics analysis and improve reproducibility, we present SPEEDI (Single-cell Pipeline for End to End Data Integration), a fully automated end-to-end framework for batch inference, data integration, and cell type labeling. SPEEDI introduces data-driven batch inference and transforms the often heterogeneous data matrices obtained from different samples into a uniformly annotated and integrated dataset. Without requiring user input, it automatically selects parameters and executes pre-processing, sample integration, and cell type mapping. It can also perform downstream analyses of differential signals between treatment conditions and gene functional modules. SPEEDI’s data-driven batch inference method works with widely used integration and cell-typing tools. By developing data-driven batch inference, providing full end-to-end automation, and eliminating parameter selection, SPEEDI improves reproducibility and lowers the barrier to obtaining biological insight from these valuable single-cell datasets. The SPEEDI interactive web application can be accessed at https://speedi.princeton.edu/ .

31 August 2023 in Nature Computational Science
Verified
Journal Article
Open access
PDF file
XCXi Chen
Xi Chen
YWYuan Wang
Yuan Wang
ACAntonio Cappuccio
Antonio Cappuccio
WCWan-Sze Cheng
Wan-Sze Cheng
FZFrederique Ruf Zamojski
Frederique Ruf Zamojski
SSStuart C. Sealfon
Stuart C. Sealfon